Georgia Bio to Showcase State’s Leadership and Patients’ Perspectives in Bioscience Innovation at 2019 Innovation Summit

Atlanta, Georgia (September 26, 2019) – The Georgia Bio Innovation Summit is the southeast’s largest life science conference, showcasing Georgia’s leadership in innovation to improve the health and well-being of people, animals and the environment. This year’s Summit will bring together hundreds of CEOs, senior executives, scientists and public policy officials from Georgia and across the nation on October 8 at the Cobb Galleria in Atlanta.

How important is the life sciences industry to the state of Georgia? From 2007 to 2017, employment in life sciences grew by 14.9%, compared to 7.7% nationally, and 8.7% growth in private employment across all industries in the state.” An RTI report for Georgia Bio published earlier this year identified 1,960 unique life science establishments that contributed 68,300 jobs and $10 billion to Georgia’s Gross Domestic Product. Accounting for multiplier effects, the industry supports a total of approximately 194,000 jobs and contributes $21.8 billion to Georgia’s GDP.

The 2019 Breakfast Keynote is entitled ”Connecting Healthcare” from Dr. Jean-Christophe Tellier, UCB Global CEO. The Luncheon Keynote Address “Personalized Health in a Chaotic Environment” will be delivered by Marc Boutin, CEO of the National Health Council

“In order to innovate, first and foremost, we must connect the patient to the science,” Tellier told the Harvard Club of Belgium. “We are moving from treating the group of patients on one criteria [towards] a better understanding of patient subpopulations and trying to define much more precise solutions that better match their needs based on biologic signatures.”

Georgia Bio is putting special emphasis on the patient’s perspective into this year’s event. What does patient-centricity really mean in an industry that comprises 20 percent of the U.S. economy? We will hear from four local members of the International Children’s Advisory Network; young advocates for the importance of the patient’s voice in pediatric care. High school senior Ayana Ganesh, sophomore Ava Meisner, eighth grader Kalee Polk, junior Maci Yeager and moderator Leanne West who will share their first person accounts of what patient centricity and the importance of the patient voice means in pediatric care.

View the full program agenda here.

Did you know, according to AdvaMed, Fortune 500 companies with more than three women on the Board have 66% higher return on invested capital and a 42% higher return on sales?

Given those statistics, to ensure we hear directly from the voice of the patient, and to build awareness among aspiring young women for what is attainable in our industry, we have intentionally stacked our presenting faculty with women leading the state’s life science sector. Read more about the industry leading women in Georgia’s life sciences presenting. 

“We are entirely confident the 2019 edition of the Georgia Bio Innovation Summit will be of high value for any and all with an interest in Georgia’s life science community and driving better treatments and care to patients in Georgia and around the globe,” says Georgia Bio President and CEO Maria Thacker-Goethe.

Register here

About Georgia Bio

Georgia Bio is the state’s trade association committed to driving growth in Georgia’s biosciences industry and its many sectors, including agri-biotech, food and nutrition, bio-based technologies and renewable chemicals, industrial and environmental biotech, medical devices and technologies, pharmaceuticals and consumer healthcare, diagnostics and research products, testing and research services, and clinical research. Georgia Bio members include bioscience companies, academic and research institutions, bioscience service providers, digital health companies, and related organizations. For more information, visit www.gabio.org or follow us on Twitter @Georgia_Bio

Editor’s Note: Registration is complimentary for credentialed members of the news media. To request media registration, please contact Kristina Forbes at kforbes@gabio.org | 404-920-2043. 

Media Contact: 
Kristina Forbes
404-920-2043
kforbes@gabio.org

By Sheran Brown June 27, 2025
Study Finds Trump’s Most Favored Nation Drug Proposal Could Still Raise Out-of-Pocket Costs Without PBM Reform Editorial Staff : June 25, 2025 Study Finds Trump’s Most Favored Nation Drug Proposal Could Still Raise Out-of-Pocket Costs Without PBM Reform - Pioneer Institute
By Sheran Brown June 26, 2025
Bipartisan House Caucus Will Advance Domestic Bioeconomy and Competitive Posture House.gov : June 26, 2025 REPRESENTATIVES HOULAHAN, BICE ANNOUNCE BIOTECH CAUCUS 
By Sheran Brown June 24, 2025
The Life Sciences Workforce Collaborative (LSWC) has released the 2025 Life Sciences Workforce Trends Report—offering one of the most comprehensive pictures to date of the hiring, training, and talent dynamics shaping the future of the industry. Developed in partnership with TEConomy Partners, LLC , and supported by InnovATEBIO , this seventh edition of the biennial report is based on a rich set of national data: ● Survey responses from over 500 life sciences companies across 30 states and Puerto Rico ● Executive interviews with more than 200 industry leaders ● Analysis of 2.9 million unique job postings from the past four years Together, these inputs paint a nuanced picture of a sector in transition—where innovation is thriving, but economic pressures and rapid technological change are forcing organizations to rethink their workforce strategies. Slower Growth, But Not a Slowdown in Strategy The report finds that after several years of rapid post-pandemic hiring, the U.S. life sciences industry experienced a modest employment contraction of 0.3% in 2024. Hiring has become more strategic, and companies are shifting focus from volume to value—investing in automation, workforce upskilling, and future-forward technologies. Despite the hiring slowdown, long-term growth indicators are strong: more than $200 billion in U.S. life sciences manufacturing and R&D investments have been announced by major companies including Johnson & Johnson, Eli Lilly, Merck, Regeneron, and others. These expansions point to sustained demand for a skilled, resilient, and adaptable workforce. AI, Automation, and the Rise of Hybrid Talent One of the clearest trends in the report is the growing integration of AI, machine learning, and industrial automation across R&D, regulatory, and manufacturing operations. Larger companies are leading adoption, but small and mid-sized firms are quickly following. As these technologies become embedded in daily workflows, employers are seeking “bilingual” workers—those with both technical life sciences expertise and digital fluency. From AI-powered regulatory documentation to predictive maintenance in biomanufacturing, tomorrow’s workforce must be prepared to operate at the intersection of science and software. --- Upskilling, Not Just Hiring With lower turnover and cautious new hiring, many life sciences companies are turning inward—investing more heavily in their existing workforce. Employers report increasing reliance on internal training, microcredentialing, and competency-based assessments, particularly for technical production roles, quality assurance, and regulatory functions. Performance-based credentialing programs, like those offered by the Bioscience Core Skills Institute (BCSI), are helping bridge gaps between traditional education and job-readiness—especially for entry-level and mid-career talent. STEM Engagement Surging Nationwide The report also highlights a remarkable rise in employer involvement in STEM education. Compared to two years ago, more than twice as many companies report engaging with K–12 students through classroom visits, mentorship programs, science fairs, and summer camps. At the postsecondary level, internships, co-op programs, and apprenticeships are helping to build direct pathways into the workforce. Nearly 80% of companies surveyed are actively offering internships to students from four-year institutions, and nearly two-thirds to community college students. This surge in engagement reflects a broader industry focus on ensuring a future-ready talent pipeline—starting early and growing local. Why This Report Matters For employers, educators, and policymakers, the 2025 Life Sciences Workforce Trends Report is more than a snapshot—it’s a strategic tool. With workforce challenges affecting everything from drug development to supply chain resilience, coordinated, data-informed action is more urgent than ever. “This report illustrates a new era in workforce dynamics—where slower overall growth is paired with opportunity in key areas, growing emphasis on upskilling, and a shift toward technology-integrated roles,” said Liisa Bozinovic, Executive Director of Oregon Bio and Chair of LSWC. “At BIO, we are proud to support these efforts and to champion policies that strengthen our industry’s talent pipeline, from the classroom to the lab and beyond,” added John Crowley, President & CEO of the Biotechnology Innovation Organization (BIO). “As noted by the National Security Commission on Emerging Biotechnology, keeping pace with the rapidly evolving skills and talent needs of the biotechnology sector is essential to U.S. leadership in this industry,” said Linnea Fletcher, Principal Investigator at InnovATEBIO. “Our national network of advanced technical education programs is working nimbly to build the next generation of biotech talent—one that is diverse, industry-aligned, and ready to power the biotechnology revolution.” --- Access the Full Report The full 2025 Life Sciences Workforce Trends Report is now available to download: https://www.lifesciencesworkforce.org/national-workforce-trends To learn more about the Life Sciences Workforce Collaborative and how your organization can engage, visit: www.LifeSciencesWorkforce.org Follow LSWC on social media for highlights and updates: 🔹 Twitter/X: X: @LifeSciWork 🔹 LinkedIn: Life Sciences Workforce Collaborative 🔹 Instagram: @lifesciworkforce 🔹 YouTube: @lifesciworkforce
MORE POSTS